Erratum to: Fibroblast growth factor receptor 2 (FGFR2) fusions in Japanese patients with intrahepatic cholangiocarcinoma

Author:

Tsujie Masanori1ORCID,Iwai Tomohisa2,Kubo Shoji3,Ura Takashi4,Hatano Etsuro5,Sakai Daisuke6,Takeda Yutaka7,Kaibori Masaki8,Kobayashi Tomoe9,Katanuma Akio10,Katayose Yu11,Fukase Koji12,Sakurai Naoki13,Ito Yukiko14,Sato Fumiya15,Maeda Atsuyuki16,Asada Masanori17,Morizane Chigusa18

Affiliation:

1. Department of Surgery, Osaka Rosai Hospital, Osaka, Japan

2. Department of Gastroenterology, Kitasato University Hospital, Sagamihara, Japan

3. Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Hospital, Osaka

4. Department of Clinical Oncology, National Hospital Organization Kyoto Medical Center, Kyoto, Japan

5. Department of Gastroenterological Surgery, Hyogo College of Medicine, Nishinomiya, Japan

6. Department of Gastroenterological Surgery, Osaka University Hospital, Suita, Japan

7. Department of Gastroenterological Surgery, Kansai Rosai Hospital, Amagasaki, Japan

8. Department of Surgery, Kansai Medical University, Osaka, Japan

9. Department of Gastroenterology and Hematology, Tomakomai City Hospital, Tomakomai, Japan

10. Center for Gastroenterology, Teine-Keijinkai Hospital, Sapporo, Japan

11. Department of Hepato-Biliary Pancreatic Surgery, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Japan

12. Department of Surgery, Japanese Red Cross Ishinomaki Hospital, Ishinomaki, Japan

13. Department of Surgery, Yamagata Prefectural Central Hospital, Yamagata, Japan

14. Department of Gastroenterology, Japanese Red Cross Medical Center, Tokyo, Japan

15. Department of Surgery, Kasugai Municipal Hospital, Kasugai, Japan

16. Department of Surgery, Ogaki Municipal Hospital, Ogaki, Japan

17. Department of Gastroenterology and Hepatology, Japanese Red Cross Osaka Hospital, Osaka, Japan

18. Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan

Funder

Taiho Pharmaceutical Co., Ltd

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3